• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CBZ
Click for more information
0.00% 5.2¢

CBIO LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CBZCeasing to be a substantial holder04/09/12
CBZChange of Issuer Code to IVX04/09/12
CBZChange of Director's Interest Notice04/09/12
CBZChange of Director's Interest Notice04/09/12
CBZBecoming a substantial holder Mitchell Glass04/09/12
CBZBecoming a substantial holder William Garner04/09/12
CBZBecoming a substantial holder Invion Limited04/09/12
CBZInitial Director's Interest Notice31/08/12
CBZInitial Director's Interest Notice31/08/12
CBZAppendix 3B31/08/12
CBZChange of name to Invion Limited31/08/12
CBZFDA ResponsePRICE SENSITIVE31/08/12
CBZMerger Transaction CompletePRICE SENSITIVE31/08/12
CBZResults of Meeting30/08/12
CBZAnnouncement Shareholders approve merger30/08/12
CBZResults of Meeting30/08/12
CBZChairman's Address to Shareholders30/08/12
CBZAnnual Report to shareholders and Appendix 4EPRICE SENSITIVE27/08/12
CBZUpdate R&D tax credit, financial positionPRICE SENSITIVE16/08/12
CBZCBio submits pre-IND request to FDA06/08/12
CBZAmended Appendix 3X and Amended Appendix 3Y06/08/12
CBZNotice of General Meeting/Proxy Form31/07/12
CBZNotice of General Meeting/Proxy Form30/07/12
CBZAnnouncement regarding Notice of Meeting30/07/12
CBZContinuous Disclosure Policy26/07/12
CBZDiversity Policy26/07/12
CBZSecurities Trading Policy26/07/12
CBZCorporate Governance Charter26/07/12
CBZGovernance update26/07/12
CBZAppendix 4C - quarterlyPRICE SENSITIVE23/07/12
CBZAppendix 3B02/07/12
CBZIndependent Expert's ReportPRICE SENSITIVE02/07/12
CBZProposed Merger with Inverseon IncPRICE SENSITIVE02/07/12
CBZUpdate25/06/12
CBZResponse to ASX Price QueryPRICE SENSITIVE14/05/12
CBZAppendix 4C - quarterlyPRICE SENSITIVE27/04/12
CBZChange of Director's Interest Notice26/04/12
CBZDetails of Company Address26/04/12
CBZAnnouncement Company Secretary Appointment20/04/12
CBZStrategic UpdatePRICE SENSITIVE10/04/12
CBZUpdate Strategic ReviewPRICE SENSITIVE29/02/12
CBZInitial Director's Interest Notice x 227/02/12
CBZFinal Director's Interest Notice27/02/12
CBZBoard and Management ChangesPRICE SENSITIVE27/02/12
CBZAppendix 4D and Half Year Financials 30 December 2011PRICE SENSITIVE24/02/12
CBZAppendix 3B16/02/12
CBZResponse to Appendix 4C ASX queryPRICE SENSITIVE06/02/12
CBZRelease of escrow securities01/02/12
CBZAppendix 4C - quarterlyPRICE SENSITIVE30/01/12
CBZRevised Share Trading Policy19/01/12
CBZShareholder UpdatePRICE SENSITIVE18/01/12
CBZAppointment of Alternate Director and Appendix 3X17/01/12
CBZRepayment of Convertible Notes30/12/11
CBZFinal Director's Interest Notice x 228/12/11
CBZResignations from the Board of Directors28/12/11
CBZChange of Director's Interest Notice21/12/11
CBZAmended Change of Director's Interest Notice21/12/11
CBZClarification to Response letter21/12/11
CBZResponse to ASX queryPRICE SENSITIVE21/12/11
CBZChange of Director's Interest Notice19/12/11
CBZUpdate Novo Nordisk Option AgreementPRICE SENSITIVE16/12/11
CBZShareholder update13/12/11
CBZFinal Director's Interest Notices X 302/12/11
CBZAppointments and Reduction in Directors FeesPRICE SENSITIVE02/12/11
CBZResults of Meeting30/11/11
CBZAGM Chairman's address29/11/11
CBZResignations from the Board of Directors29/11/11
CBZFinal Director's Interest Notices x 225/11/11
CBZChange of Director's Interest Notices x 325/11/11
CBZCBio Clinical Trial Data presented at ACR Meeting23/11/11
CBZResignations from the Board of Directors21/11/11
CBZCorrection to Investment Presentation 19 Sept 201121/11/11
CBZReplacement 2011 AGM meeting documents11/11/11
CBZInitial Director's Interest Notices x 510/11/11
CBZCeasing to be a substantial holder10/11/11
CBZCBio addresses shareholder feedback07/11/11
CBZAppointment of New Non-Executive Directors04/11/11
CBZCleansing statement04/11/11
CBZResults of Meeting04/11/11
CBZFinal Director's Interest Notices x 304/11/11
CBZAppendix 3B04/11/11
CBZResignations from Board of Directors01/11/11
CBZPlacementPRICE SENSITIVE01/11/11
CBZAppendix 4C - quarterlyPRICE SENSITIVE31/10/11
CBZLupus Data Published By Oxford Journals28/10/11
CBZTrading HaltPRICE SENSITIVE28/10/11
CBZCompany Secretary Appointment/Resignation27/10/11
CBZCBio Data To Be Presened To American College of Rheumatology26/10/11
CBZFinal Director's Interest Notice26/10/11
CBZBoard and Management Change26/10/11
CBZSection 708A Notice26/10/11
CBZAppendix 3B26/10/11
CBZShortfall Allotment26/10/11
CBZLetter to Shareholders21/10/11
CBZChange of Director's Interest Notice x 220/10/11
CBZNotice of Annual General Meeting/Proxy Form20/10/11
CBZReceipt of Final Clinical Study ReportPRICE SENSITIVE17/10/11
CBZRights Issue Share Allotment17/10/11
CBZShortfall AnnouncementPRICE SENSITIVE12/10/11
CBZBoard and Executive Changes12/10/11
CBZCeasing to be a substantial holder
04/09/12
CBZChange of Issuer Code to IVX
04/09/12
CBZChange of Director's Interest Notice
04/09/12
CBZChange of Director's Interest Notice
04/09/12
CBZBecoming a substantial holder Mitchell Glass
04/09/12
CBZBecoming a substantial holder William Garner
04/09/12
CBZBecoming a substantial holder Invion Limited
04/09/12
CBZInitial Director's Interest Notice
31/08/12
CBZInitial Director's Interest Notice
31/08/12
CBZAppendix 3B
31/08/12
CBZChange of name to Invion Limited
31/08/12
CBZFDA Response
31/08/12PRICE SENSITIVE
CBZMerger Transaction Complete
31/08/12PRICE SENSITIVE
CBZResults of Meeting
30/08/12
CBZAnnouncement Shareholders approve merger
30/08/12
CBZResults of Meeting
30/08/12
CBZChairman's Address to Shareholders
30/08/12
CBZAnnual Report to shareholders and Appendix 4E
27/08/12PRICE SENSITIVE
CBZUpdate R&D tax credit, financial position
16/08/12PRICE SENSITIVE
CBZCBio submits pre-IND request to FDA
06/08/12
CBZAmended Appendix 3X and Amended Appendix 3Y
06/08/12
CBZNotice of General Meeting/Proxy Form
31/07/12
CBZNotice of General Meeting/Proxy Form
30/07/12
CBZAnnouncement regarding Notice of Meeting
30/07/12
CBZContinuous Disclosure Policy
26/07/12
CBZDiversity Policy
26/07/12
CBZSecurities Trading Policy
26/07/12
CBZCorporate Governance Charter
26/07/12
CBZGovernance update
26/07/12
CBZAppendix 4C - quarterly
23/07/12PRICE SENSITIVE
CBZAppendix 3B
02/07/12
CBZIndependent Expert's Report
02/07/12PRICE SENSITIVE
CBZProposed Merger with Inverseon Inc
02/07/12PRICE SENSITIVE
CBZUpdate
25/06/12
CBZResponse to ASX Price Query
14/05/12PRICE SENSITIVE
CBZAppendix 4C - quarterly
27/04/12PRICE SENSITIVE
CBZChange of Director's Interest Notice
26/04/12
CBZDetails of Company Address
26/04/12
CBZAnnouncement Company Secretary Appointment
20/04/12
CBZStrategic Update
10/04/12PRICE SENSITIVE
CBZUpdate Strategic Review
29/02/12PRICE SENSITIVE
CBZInitial Director's Interest Notice x 2
27/02/12
CBZFinal Director's Interest Notice
27/02/12
CBZBoard and Management Changes
27/02/12PRICE SENSITIVE
CBZAppendix 4D and Half Year Financials 30 December 2011
24/02/12PRICE SENSITIVE
CBZAppendix 3B
16/02/12
CBZResponse to Appendix 4C ASX query
06/02/12PRICE SENSITIVE
CBZRelease of escrow securities
01/02/12
CBZAppendix 4C - quarterly
30/01/12PRICE SENSITIVE
CBZRevised Share Trading Policy
19/01/12
CBZShareholder Update
18/01/12PRICE SENSITIVE
CBZAppointment of Alternate Director and Appendix 3X
17/01/12
CBZRepayment of Convertible Notes
30/12/11
CBZFinal Director's Interest Notice x 2
28/12/11
CBZResignations from the Board of Directors
28/12/11
CBZChange of Director's Interest Notice
21/12/11
CBZAmended Change of Director's Interest Notice
21/12/11
CBZClarification to Response letter
21/12/11
CBZResponse to ASX query
21/12/11PRICE SENSITIVE
CBZChange of Director's Interest Notice
19/12/11
CBZUpdate Novo Nordisk Option Agreement
16/12/11PRICE SENSITIVE
CBZShareholder update
13/12/11
CBZFinal Director's Interest Notices X 3
02/12/11
CBZAppointments and Reduction in Directors Fees
02/12/11PRICE SENSITIVE
CBZResults of Meeting
30/11/11
CBZAGM Chairman's address
29/11/11
CBZResignations from the Board of Directors
29/11/11
CBZFinal Director's Interest Notices x 2
25/11/11
CBZChange of Director's Interest Notices x 3
25/11/11
CBZCBio Clinical Trial Data presented at ACR Meeting
23/11/11
CBZResignations from the Board of Directors
21/11/11
CBZCorrection to Investment Presentation 19 Sept 2011
21/11/11
CBZReplacement 2011 AGM meeting documents
11/11/11
CBZInitial Director's Interest Notices x 5
10/11/11
CBZCeasing to be a substantial holder
10/11/11
CBZCBio addresses shareholder feedback
07/11/11
CBZAppointment of New Non-Executive Directors
04/11/11
CBZCleansing statement
04/11/11
CBZResults of Meeting
04/11/11
CBZFinal Director's Interest Notices x 3
04/11/11
CBZAppendix 3B
04/11/11
CBZResignations from Board of Directors
01/11/11
CBZPlacement
01/11/11PRICE SENSITIVE
CBZAppendix 4C - quarterly
31/10/11PRICE SENSITIVE
CBZLupus Data Published By Oxford Journals
28/10/11
CBZTrading Halt
28/10/11PRICE SENSITIVE
CBZCompany Secretary Appointment/Resignation
27/10/11
CBZCBio Data To Be Presened To American College of Rheumatology
26/10/11
CBZFinal Director's Interest Notice
26/10/11
CBZBoard and Management Change
26/10/11
CBZSection 708A Notice
26/10/11
CBZAppendix 3B
26/10/11
CBZShortfall Allotment
26/10/11
CBZLetter to Shareholders
21/10/11
CBZChange of Director's Interest Notice x 2
20/10/11
CBZNotice of Annual General Meeting/Proxy Form
20/10/11
CBZReceipt of Final Clinical Study Report
17/10/11PRICE SENSITIVE
CBZRights Issue Share Allotment
17/10/11
CBZShortfall Announcement
12/10/11PRICE SENSITIVE
CBZBoard and Executive Changes
12/10/11
refresh Created with Sketch. REFRESH
 

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.